首頁 > 市場調查報告書 > 醫療設備

病患監測

市場調查報告書

商品編碼

1576933

生命徵象監測設備:市場洞察·競爭環境·市場預測 (～2030年)

Vital Sign Monitoring Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

出版日期: 2024年10月01日 | 出版商:

DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

簡介目錄圖表

全球生命徵象監測設備市場規模預計將從 2023 年的 75.9 億美元成長到 2030 年的 119.7 億美元，預計 2024-2030 年的複合年增長率將達到 7.94%。

高血壓、糖尿病、呼吸系統疾病和心血管疾病等慢性病的盛行率不斷上升，推動了對生命徵象監測儀的需求。全球健康意識的轉變也推動了這種需求，越來越多的消費者每天使用穿戴式健身設備來追蹤他們的生命體徵。隨著此類監測功能被整合到通用設備中以及產品開發的進步，數位健康和遠距醫療計畫正在加速生命徵象監測器的採用，特別是自 COVID-19 以來。因此，預計2024年至2030年市場將快速成長。

生命徵象監測儀市場動態：

根據英國心臟基金會2024年的最新數據，全球約有6.2億人，約每13人中就有1人患有心臟和循環系統疾病。此外，根據同一數據，2021年歐洲有1億人患有心臟病和循環系統疾病，亞洲和澳洲有3.4億人患有心臟病和循環系統疾病。此外，冠狀動脈（缺血性）心臟病是世界上最常診斷的疾病，估計影響全球 2 億人。冠狀動脈疾病、心臟衰竭、心律不整和高血壓等心血管疾病需要密切監測心率、血壓和血氧飽和度等生命體徵，以有效管理疾病並預防心臟病發作和中風等急性事件。生命徵象監測儀使患者和醫療保健提供者能夠即時追蹤這些重要指標，從而及早發現異常情況並及時進行幹預。鑑於這些，心臟病等慢性疾病的日益普及正在推動生命徵象監測儀市場的發展。

此外，根據國際糖尿病聯盟 2024 年的數據，2021 年全球約有 5.37 億成年人（十分之一）患有糖尿病。預計到 2030 年，這一數字將增至 6.43 億，到 2045 年將增至 7.83 億。糖尿病管理需要定期監測血糖水平，但糖尿病患者出現心血管併發症、高血壓和其他相關健康問題的風險較高，例如血壓、心率和血氧飽和度等其他生命體徵。生命徵象監測儀，尤其是那些整合了血糖監測功能的監測儀，可以全面了解患者的健康狀況。這種持續監測對於預防糖尿病患者常見的糖尿病神經病變、視網膜病變和心血管事件等併發症至關重要。

本報告提供全球生命徵象監測設備的市場調查，提供市場概要，市場影響因素及市場機會分析，法律制度，市場規模的轉變·預測，各種區分·地區/各主要國家的詳細分析，競爭情形，主要企業簡介等資訊。

推動市場要素
- 糖尿病、呼吸系統疾病和心血管疾病等慢性疾病的盛行率不斷上升
- 健康意識不斷提高，健身追蹤日益普及
- 擴大全球產品開發
阻礙市場要素·課題
- 無線生命徵象監測儀的數據和隱私問題
- 對血液循環不良、皮膚色素沉著、厚度和溫度測量準確性的擔憂
市場機會
- 居家醫療保健和遠距病患監控的趨勢日益明顯

第6章生理監護器市場:波特的五力分析

第7章生理監護器市場:市場評估

各產品類型
- 獨立式
- 複合型
各終端用戶
- 醫院
- 診所
- 居家照護
- 其他
各地區
- 北美
- 歐洲
- 亞太地區
- 其他地區

第8章生理監護器市場:企業·產品簡介

Masimo
Koninklijke Philips N.V.
NIHON KOHDEN CORPORATION.
B Nonin Medical
Omron
ACCOSON
Advin Health Care
Lepu Medical Technology
TytoCare Ltd.
VYAIRE
SCHILLER
SunTech Medical, Inc.
Welch Allyn Inc.
Medtronic PLC
GENERAL ELECTRIC COMPANY
Contec Medical Systems Limited
Biobeat
Honsun
Rudolf Riester GmbH
Promed Technology

第9章 KOL的見解

第10章計劃方法

第11章關於DelveInsight

第12章免責聲明·諮詢方式

簡介目錄圖表

Product Code: DIMDCL0198

Vital Sign Monitors by Product Type (Standalone Monitoring Devices [Blood Pressure Monitoring Devices {Mercury Blood Pressure Monitors, Aneroid Blood Pressure Monitors, Automated Blood Pressure Monitors, and Others}, Pulse Oximeters {Fingertip Pulse Oximeters, Handheld Pulse Oximeters, Bench Top Pulse Oximeters, and Wearable Pulse Oximeters}, Temperature Monitoring Devices {Digital Thermometers, Infrared Thermometers, and Others}, Others] and Combined Monitoring Devices), By End-User (Hospitals, Clinics, Home Care Settings, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2030 owing to the increase in prevalence of chronic diseases, increasing health consciousness and the popularity of fitness tracking, and increased in product developmental activities across the globe.

The global vital sign monitors market was valued at USD 7.59 billion in 2023, growing at a CAGR of 7.94% during the forecast period from 2024 to 2030, to reach USD 11.97 billion by 2030. The rising prevalence of chronic conditions like hypertension, diabetes, respiratory, and cardiovascular diseases is driving the demand for vital sign monitors. Additionally, this demand is bolstered by a global shift towards health-conscious behavior, with more consumers using wearable fitness devices to track vital signs daily. The integration of these monitoring capabilities into popular devices, along with advancements in product development, and the push towards digital health and telemedicine, especially post-COVID-19 are accelerating the adoption of vital sign monitors. As a result, the market is poised for rapid growth from 2024 to 2030.

Vital Sign Monitors Market Dynamics:

According to a recent data provided by British Heart Foundation (2024), globally, approximately 620 million people, or about 1 in 13 individuals, live with heart and circulatory diseases. Additionally, as per the same source, the prevalence of heart and circulatory diseases was 100 million in Europe and 340 million in Asia and Australia in 2021. Furthermore, as per the recent data provided by the British Heart Foundation (2024), coronary (ischemic) heart disease, the most commonly diagnosed worldwide, affected an estimated 200 million people globally. Cardiovascular conditions, such as coronary artery disease, heart failure, arrhythmias, and hypertension, require vigilant monitoring of vital signs like heart rate, blood pressure, and oxygen saturation to manage the disease effectively and prevent acute events like heart attacks or strokes. Vital sign monitors enable patients and healthcare providers to track these key indicators in real-time, allowing for early detection of abnormalities and timely interventions. Thus, the growing prevalence of chronic disorders such as cardiac disease, boost the market of vital sign monitors.

Furthermore, as per the International Diabetes Federation (2024), in 2021, globally, approximately, 537 million adults (1 in 10) were living with diabetes. This number was expected rise to 643 million by 2030 and 783 million by 2045. Diabetes management requires regular monitoring of blood glucose levels, but it also involves closely tracking other vital signs such as blood pressure, heart rate, and oxygen saturation, as people with diabetes are at higher risk for cardiovascular complications, hypertension, and other related health issues. Vital sign monitors, particularly those integrated with glucose monitoring capabilities, enable patients to maintain a comprehensive view of their overall health. This continuous monitoring is crucial for preventing complications such as diabetic neuropathy, retinopathy, and cardiovascular events, which are common among diabetic patients.

Additionally, companies are amplifying their production of vital sign monitors and launching the new products, thereby strategically expanding their market presence and driving further growth. For instance, in April, 2024, GE HealthCare announced that it had received 510(k) clearance from the FDA for its Portrait VSM vital signs monitor. The device, is an evolution of the DINAMAP legacy, used the SuperSTAT non-invasive blood pressure algorithm for precise readings.

Thus, the factors mentioned above are likely to boost the market of vital sign monitors during the forecasted period.

However, data and privacy concerns for wireless vital sign monitors and accuracy concerns of readings due to poor circulation, skin pigmentation, thickness, and temperature may hinder the future market of vital sign monitors.

Vital Sign Monitors Market Segment Analysis:

In the vital sign monitors product segment, the pulse oximeters which are further sub-categorized into fingertip pulse oximeter are expected to hold a significant market share in 2023. Fingertip pulse oximeters are significantly boosting the overall market for vital sign monitors through their convenience, accessibility, and increasing integration with advanced technology. As non-invasive devices that measure blood oxygen saturation and pulse rate, fingertip pulse oximeters have gained immense popularity, particularly during the COVID-19 pandemic, when there was a heightened demand for remote monitoring solutions. The ease of use and portability of fingertip pulse oximeters make them ideal for both clinical settings and home healthcare, facilitating continuous monitoring and enhancing patient engagement. Innovations in technology, such as wireless connectivity and integration with mobile applications, have further propelled their adoption, allowing patients and healthcare providers to track vital signs in real-time.

In addition, new product launches are also likely to upsurge the global fingertip pulse oximeter market during the forecasted period. For instance, in February 2024, Masimo announced FDA clearance of MightySat(R) Medical, making it the first and only FDA-cleared medical fingertip pulse oximeter available Over-The-Counter (OTC) direct to consumers without a prescription.

Hence, all the above-mentioned factors are expected to generate considerable revenue of the segment pushing the overall growth of the global vital sign monitors market during the forecast period.

North America is expected to dominate the overall vital sign monitors market:

North America is expected to account for the highest proportion of the vital sign monitors market in 2023, out of all regions. This domination is due to the growing demand for advanced technologies in remote patient monitoring devices or vital sign monitors. Additionally, the increasing chronic disease in the region such as cardiovascular disorders and respiratory diseases, increased R&D funding, favorable reimbursement for these devices, and the presence of an advanced healthcare system are also the fueling factors for the vital sign monitors market in the region.

According to the recent data and stats provided by American Lung Association (2024), more than 34 million people living in the U.S. lived with a chronic lung disease like asthma and COPD. Both COPD and asthma require regular tracking of vital signs such as oxygen saturation, heart rate, and respiratory rate to manage symptoms, prevent exacerbations, and avoid hospitalizations. The growing prevalence of these respiratory diseases, along with the emphasis on home-based care and telehealth solutions, drives demand for portable, user-friendly vital sign monitors thereby escalating the market across the region.

According to recent data from the Centers for Disease Control and Prevention (2024), in 2022, approximately 4.9% of adults were diagnosed with coronary heart disease in the United States. Furthermore, by 2023, an estimated 12.1 million individuals in the United States were projected to have atrial fibrillation. Cardiac disease boosts the market for vital sign monitors by creating a high demand for continuous tracking of heart-related metrics, such as heart rate, blood pressure, and oxygen levels. Patients with conditions like heart failure, arrhythmias, and hypertension need regular monitoring to manage their health and detect potential complications early thereby escalating the market across the region.

In addition, new product launches are also likely to upsurge the vital sign monitor market across the region during the forecasted period. For instance, in July 2022, Mindray announced the launch of its VS9 vital signs monitor, featuring a 10.1" touchscreen display. The VS9, designed for both spot check and continuous monitoring, provided tools to support clinical decisions and streamline workflows. Therefore, the above-mentioned factors are expected to bolster the growth of the vital sign monitors market in the North America during the forecast period.

Vital Sign Monitors Market Key Players:

Some of the key market players operating in the Vital Sign Monitors market include Masimo, Koninklijke Philips N.V., NIHON KOHDEN CORPORATION., Nonin Medical, Omron, ACCOSON, Advin Health Care, Lepu Medical Technology, TytoCare Ltd., VYAIRE, SCHILLER, SunTech Medical, Inc., Welch Allyn Inc., Medtronic PLC, GENERAL ELECTRIC COMPANY, Contec Medical Systems Limited, Biobeat, Honsun, Rudolf Riester GmbH, Promed Technology, and others.

Recent Developmental Activities in the Vital Sign Monitors Market:

In June 2024, Aktiia, received regulatory approval for the world's first optical blood pressure system CALFREE(TM) which can be used without the need for calibration with a regular cuff.
In March 2022, Nonin Medical, Inc. launched two new disposable products - a single-use wristband and a sensor for use with Nonin's WristOx2 3150, a wrist-worn pulse oximeter (SpO2).
In June 2021, DetelPro launched the Oxy10 pulse oximeter. This compact device has an LED display which can easily be attached to the fingertip, providing readings for oxygen saturation and pulse rate.

Key Takeaways From the Vital Sign Monitors Market Report Study:

Market size analysis for current vital sign monitors size (2023), and market forecast for 6 years (2024 to 2030)
Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
Key companies dominating the vital sign monitors market.
Various opportunities available for the other competitors in the vital sign monitors market space.
What are the top-performing segments in 2023? How these segments will perform in 2030?
Which are the top-performing regions and countries in the current vital sign monitors market scenario?
Which are the regions and countries where companies should have concentrated on opportunities for vital sign monitors market growth in the coming future?

Target Audience who can be Benefited From This Vital Sign Monitors Market Report Study:

Vital sign monitors product providers
Research organizations and consulting companies
Vital sign monitors -related organizations, associations, forums, and other alliances
Government and corporate offices
Start-up companies, venture capitalists, and private equity firms
Distributors and traders dealing in vital sign monitors
Various end-users who want to know more about the vital sign monitors market and the latest technological developments in the vital sign monitors market.

Frequently Asked Questions for the Vital Sign Monitors Market:

1. What are vital sign monitors?

Vital signs monitor are the devices that measure the basic medical indicators of health such as temperature, pulse, breathing, and blood pressure. Most of these monitors can store and record thousands of pieces of information.

2. What is the market for vital sign monitors?

The global vital sign monitors market was valued at USD 7.59 billion in 2023, growing at a CAGR of 7.94% during the forecast period from 2024 to 2030, to reach USD 11.97 billion by 2030.

3. What are the drivers for the vital sign monitors market?

The rising prevalence of chronic conditions like hypertension, diabetes, respiratory, and cardiovascular diseases is driving the demand for vital sign monitors, essential for continuous and accurate health monitoring. This demand is bolstered by a global shift towards health-conscious behaviours, with more consumers using wearable fitness devices to track vital signs daily. The integration of these monitoring capabilities into popular devices, along with advancements in product development, and the push towards digital health and telemedicine, especially post-COVID-19, are accelerating the adoption of vital sign monitors. As a result, the market is poised for rapid growth from 2024 to 2030.

4. Who are the key players operating in the vital sign monitors market?

Some of the key market players operating in the Vital Sign Monitors market include Masimo, Koninklijke Philips N.V., NIHON KOHDEN CORPORATION., Nonin Medical, Omron, ACCOSON, Advin Health Care, Lepu Medical Technology, TytoCare Ltd., VYAIRE, SCHILLER, SunTech Medical, Inc., Welch Allyn Inc., Medtronic PLC, GENERAL ELECTRIC COMPANY, Contec Medical Systems Limited, Biobeat, Honsun, Rudolf Riester GmbH, Promed Technology, and others.

5. Which region has the highest share in the vital sign monitors market?

North America is expected to account for the highest proportion of the vital sign monitors market in 2023, out of all regions. This domination is due to the growing demand for advanced technologies in remote patient monitoring devices or vital sign monitors, the increasing chronic disease in the region, and others that are driving the regional growth. Moreover, the rising prevalence of respiratory diseases, increased R&D funding, favourable reimbursement for these devices, and the presence of an advanced healthcare system are also the fueling factors for the vital sign monitors market in the region.

1. Vital Sign Monitors Market Report Introduction

1.1. Scope of the Study
1.2. Market Segmentation
1.3. Market Assumption

2. Vital Sign Monitors Market Executive Summary

2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

4.1. The United States
4.2. Europe
4.3. Japan
4.4. China

5. Vital Sign Monitors Market Key Factors Analysis

5.1. Vital Sign Monitors Market Drivers
- 5.1.1. Increase in prevalence of chronic diseases such as diabetes, respiratory disease, cardiovascular disease, and others
- 5.1.2. Increasing health consciousness and the popularity of fitness tracking
- 5.1.3. Growing product developmental activities across the globe
5.2. Vital Sign Monitors Market Restraints and Challenges
- 5.2.1. Data and privacy concerns for wireless vital sign monitors
- 5.2.2. Accuracy concerns of readings due to poor circulation, skin pigmentation, thickness, and temperature
5.3. Vital Sign Monitors Market Opportunities
- 5.3.1. Growing trends towards home-based healthcare and remote patient monitoring

6. Vital Sign Monitors Market Porter's Five Forces Analysis

6.1. Bargaining Power of Suppliers
6.2. Bargaining Power of Consumers
6.3. Threat of New Entrants
6.4. Threat of Substitutes
6.5. Competitive Rivalry

7. Vital Sign Monitors Market Assessment

7.1. By Product Type
- 7.1.1. Standalone Monitoring Devices
  - 7.1.1.1. Blood Pressure Monitoring Devices
  - 7.1.1.1.1. Mercury Blood Pressure Monitors
  - 7.1.1.1.2. Aneroid Blood Pressure Monitors
  - 7.1.1.1.3. Automated Blood Pressure Monitors
  - 7.1.1.1.4. Others
  - 7.1.1.2. Pulse Oximeter
  - 7.1.1.2.1. Fingertip Pulse Oximeters
  - 7.1.1.2.2. Handheld Pulse Oximeters
  - 7.1.1.2.3. Bench-Top Pulse Oximeters
  - 7.1.1.2.4. Wearable Pulse Oximeters
  - 7.1.1.3. Temperature Monitoring Devices
  - 7.1.1.3.1. Digital Thermometers
  - 7.1.1.3.2. Infrared Thermometers
  - 7.1.1.3.3. Others
  - 7.1.1.4. Others
- 7.1.2. Combined Monitoring Devices
7.2. By End-User
- 7.2.1. Hospitals
- 7.2.2. Clinics
- 7.2.3. Homecare Settings
- 7.2.4. Others
7.3. By Geography
- 7.3.1. North America
  - 7.3.1.1. United States Vital Sign Monitors Market Size in USD Million (2021-2030)
  - 7.3.1.2. Canada Vital Sign Monitors Market Size in USD Million (2021-2030)
  - 7.3.1.3. Mexico Vital Sign Monitors Market Size in USD Million (2021-2030)
- 7.3.2. Europe
  - 7.3.2.1. France Vital Sign Monitors Market Size in USD Million (2021-2030)
  - 7.3.2.2. Germany Vital Sign Monitors Market Size in USD Million (2021-2030)
  - 7.3.2.3. United Kingdom Vital Sign Monitors Market Size in USD Million (2021-2030)
  - 7.3.2.4. Italy Vital Sign Monitors Market Size in USD Million (2021-2030)
  - 7.3.2.5. Spain Vital Sign Monitors Market Size in USD Million (2021-2030)
  - 7.3.2.6. Rest of Europe Vital Sign Monitors Market Size in USD Million (2021-2030)
- 7.3.3. Asia-Pacific
  - 7.3.3.1. China Vital Sign Monitors Market Size in USD Million (2021-2030)
  - 7.3.3.2. Japan Vital Sign Monitors Market Size in USD Million (2021-2030)
  - 7.3.3.3. India Vital Sign Monitors Market Size in USD Million (2021-2030)
  - 7.3.3.4. Australia Vital Sign Monitors Market Size in USD Million (2021-2030)
  - 7.3.3.5. South Korea Vital Sign Monitors Market Size in USD Million (2021-2030)
  - 7.3.3.6. Rest of Asia-Pacific Vital Sign Monitors Market Size in USD Million (2021-2030)
- 7.3.4. Rest of the World (RoW)
  - 7.3.4.1. Middle East Vital Sign Monitors Market Size in USD Million (2021-2030)
  - 7.3.4.2. Africa Vital Sign Monitors Market Size in USD Million (2021-2030)
  - 7.3.4.3. South America Vital Sign Monitors Market Size in USD Million (2021-2030)

8. Vital Sign Monitors Market Company and Product Profiles

8.1. Masimo
- 8.1.1. Company Overview
- 8.1.2. Company Snapshot
- 8.1.3. Financial Overview
- 8.1.4. Product Listing
- 8.1.5. Entropy
8.2. Koninklijke Philips N.V.
- 8.2.1. Company Overview
- 8.2.2. Company Snapshot
- 8.2.3. Financial Overview
- 8.2.4. Product Listing
- 8.2.5. Entropy
8.3. NIHON KOHDEN CORPORATION.
- 8.3.1. Company Overview
- 8.3.2. Company Snapshot
- 8.3.3. Financial Overview
- 8.3.4. Product Listing
- 8.3.5. Entropy
8.4. B Nonin Medical
- 8.4.1. Company Overview
- 8.4.2. Company Snapshot
- 8.4.3. Financial Overview
- 8.4.4. Product Listing
- 8.4.5. Entropy
8.5. Omron
- 8.5.1. Company Overview
- 8.5.2. Company Snapshot
- 8.5.3. Financial Overview
- 8.5.4. Product Listing
- 8.5.5. Entropy
8.6. ACCOSON
- 8.6.1. Company Overview
- 8.6.2. Company Snapshot
- 8.6.3. Financial Overview
- 8.6.4. Product Listing
- 8.6.5. Entropy
8.7. Advin Health Care
- 8.7.1. Company Overview
- 8.7.2. Company Snapshot
- 8.7.3. Financial Overview
- 8.7.4. Product Listing
- 8.7.5. Entropy
8.8. Lepu Medical Technology
- 8.8.1. Company Overview
- 8.8.2. Company Snapshot
- 8.8.3. Financial Overview
- 8.8.4. Product Listing
- 8.8.5. Entropy
8.9. TytoCare Ltd.
- 8.9.1. Company Overview
- 8.9.2. Company Snapshot
- 8.9.3. Financial Overview
- 8.9.4. Product Listing
- 8.9.5. Entropy
8.10. VYAIRE
- 8.10.1. Company Overview
- 8.10.2. Company Snapshot
- 8.10.3. Financial Overview
- 8.10.4. Product Listing
- 8.10.5. Entropy
8.11. SCHILLER
- 8.11.1. Company Overview
- 8.11.2. Company Snapshot
- 8.11.3. Financial Overview
- 8.11.4. Product Listing
- 8.11.5. Entropy
8.12. SunTech Medical, Inc.
- 8.12.1. Company Overview
- 8.12.2. Company Snapshot
- 8.12.3. Financial Overview
- 8.12.4. Product Listing
- 8.12.5. Entropy
8.13. Welch Allyn Inc.
- 8.13.1. Company Overview
- 8.13.2. Company Snapshot
- 8.13.3. Financial Overview
- 8.13.4. Product Listing
- 8.13.5. Entropy
8.14. Medtronic PLC
- 8.14.1. Company Overview
- 8.14.2. Company Snapshot
- 8.14.3. Financial Overview
- 8.14.4. Product Listing
- 8.14.5. Entropy
8.15. GENERAL ELECTRIC COMPANY
- 8.15.1. Company Overview
- 8.15.2. Company Snapshot
- 8.15.3. Financial Overview
- 8.15.4. Product Listing
- 8.15.5. Entropy
8.16. Contec Medical Systems Limited
- 8.16.1. Company Overview
- 8.16.2. Company Snapshot
- 8.16.3. Financial Overview
- 8.16.4. Product Listing
- 8.16.5. Entropy
8.17. Biobeat
- 8.17.1. Company Overview
- 8.17.2. Company Snapshot
- 8.17.3. Financial Overview
- 8.17.4. Product Listing
- 8.17.5. Entropy
8.18. Honsun
- 8.18.1. Company Overview
- 8.18.2. Company Snapshot
- 8.18.3. Financial Overview
- 8.18.4. Product Listing
- 8.18.5. Entropy
8.19. Rudolf Riester GmbH
- 8.19.1. Company Overview
- 8.19.2. Company Snapshot
- 8.19.3. Financial Overview
- 8.19.4. Product Listing
- 8.19.5. Entropy
8.20. Promed Technology
- 8.20.1. Company Overview
- 8.20.2. Company Snapshot
- 8.20.3. Financial Overview
- 8.20.4. Product Listing
- 8.20.5. Entropy